Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in CELLDEX THERAPEUTICS INC NEW
BNP PARIBAS FINANCIAL MARKETS holds 175,788 shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $5.6M as of 2026-Q1. The position was decreased (-23.8% shares). CLDX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$5.6M
Current Shares
175,788
Total Value Change
+$5.3M
Total Shares Change
+168,620
Other major holders of CLDX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 175,788 |
-23.8% |
| $5.6M |
| 0.0% |
| $28.94 |
0 |
| 2025-Q4 | Increased | 230,662 | +72.3% | $6.3M | 0.0% | $26.43 | 41 |
| 2025-Q3 | Decreased | 133,883 | -36.6% | $3.5M | 0.0% | $26.19 | 0 |
| 2025-Q2 | Increased | 211,260 | +100.9% | $4.3M | 0.0% | $20.29 | 43 |
| 2025-Q1 | Increased | 105,140 | +67.9% | $1.9M | 0.0% | $19.93 | 38 |
| 2024-Q4 | Increased | 62,631 | +122.3% | $1.6M | 0.0% | $25.12 | 41 |
| 2024-Q3 | Increased | 28,181 | +293.1% | $957,872 | 0.0% | $33.20 | 40 |
| 2024-Q2 | Decreased | 7,168 | -87.2% | $265,288 | 0.0% | $37.01 | 0 |